The aim is to create an awareness programme that will drive diabetic patients to get their eyes tested regularly
Covaxin is the only Covid-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the Delta variant at 65.2%
The company will leverage existing hospital and clinic partners’ infrastructure to build specialised `Experience Centres’ and facilitate a seamless, end-to-end secondary care surgery delivery. It will also offer healthcare financing
Over 61 per cent of pharmacists stated that they aim to improve their knowledge and medical skills while 76 per cent collaborated with healthcare players to improve the outcome for their patients
BB will have access to 100 million doses of vaccines annually and commercialization rights of the SILS vaccine portfolio for global markets
The first lot of IPV will be supplied to the government this month as per the requirement of the Health Ministry
Nipah virus (NiV) is an emerging zoonotic disease that causes severe disease in humans. Signs and symptoms range from asymptomatic to acute respiratory infection and fatal encephalitis
The facility has the capacity to produce one crore doses per day
First diagnostic centre to open in Mohali on August 31
CDSCO gives the green signal as HGCO19 was safe, tolerable and immunogenic in the participants of the study
Subscribe To Our Newsletter & Stay Updated
